hat
Efè segondè andojèn yo tou se yon enkyetid, kòm Testostewòn pral fasil diminye nan Dihydrotestosterone (DHT) nan divès tisi nan tout kò a. Sa a kreye yon ogmantasyon jeneral nan efè segondè Androjenik, kòm DHT se yon Androjen pi fre pase Testostewòn tèt li se. Malgre ke Testostewòn tèt li posede modèn fòs Androjenik, pwoblèm nan manti nan DHT, ki se yon Androjen pi plis pwisan. Andedanik efè segondè yo enkli: ogmante sebous sekresyon (lwil po), ogmante epiz nan akne (lye nan ogmante sekresyon sebum), kòporèl ak feminen kwasans cheve, ak risk la ogmante nan lakòz Malej baldness modèl (MPB) nan moun ki posede karakteristik nan jenetik egzije pou kondisyon an manifeste poukont li. Sa yo efè segondè Sustanon ka redwi atravè itilizasyon 5-alpha reduktaz inhibiteurs, ak aktualite DHT antagonists, tankou Nizoral.
eng
Androgenic side effects are also a concern, as Testosterone will readily reduce into Dihydrotestosterone (DHT) in various tissues throughout the body. This creates an overall increase in androgenic side effects, as DHT is a much stronger androgen than Testosterone itself is. Although Testosterone itself possesses moderate androgenic strength, the problem lies in DHT, which is a much more powerful androgen. Androgenic side effects include: increased sebum secretion (oily skin), increased bouts of acne (linked to increased sebum secretion), bodily and facial hair growth, and the increased risk of triggering Male Pattern Baldness (MPB) in individuals that possess the genetic trait required for the condition to manifest itself. These Sustanon side effects can be mitigated through the use of 5-alpha reductase inhibitors, and topical DHT antagonists, such as Nizoral.